Clinical trials
Recruiting Phase 1 Arthritis, Rheumatoid trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 19 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 44 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 |
| Eli Lilly and Company | 2 |
| Kali Therapeutics, Inc. | 2 |
| AbbVie | 1 |
| Adicet Therapeutics | 1 |
| Bristol-Myers Squibb | 1 |
| Candid Therapeutics | 1 |
| Capstan Therapeutics | 1 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 44 |
| Lupus Erythematosus, Systemic | 18 |
| Scleroderma, Systemic | 8 |
| Autoimmune Diseases | 7 |
| Myositis | 7 |
| Sjogren's Syndrome | 4 |
| Arthritis, Psoriatic | 3 |
| Dermatomyositis | 3 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2 |
| Antiphospholipid Syndrome | 2 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.